HEALTHCARE · NSE/BSE: MAXHEALTH

Max Healthcare Institute Limited Earnings Summary — Q1 FY2027

Sentiment: Positive
AI-generated summary
Generated 2026-08-27
Generated using: Official Earnings Press Release
Business Intelligence Report

Max Healthcare Reports Steady Q1 Growth with Strategic Expansion in Odisha and Pune

Quarterly Business Intelligence

Q1 FY2027
Financials from Financial Intelligence · data as of 2026-06-30
Revenue
₹2,366 Cr
QoQ +10.4%YoY +16.7%
Net Profit
₹323 Cr
QoQ -5.6%YoY +4.9%
Operating Profit
₹598 Cr
QoQ -1.3%YoY +14.4%
Operating Margin
25.3%
QoQ -301 bpsYoY -50 bps

AI Quarterly Scorecard™

69
/ 100
Healthy
Revenue Momentum94
Profit Growth55
Margin Expansion59
Growth Consistency83
Operating Efficiency52
Financial Stability70

Computed deterministically from the last 10 reported quarters.

Quarterly Business Momentum

Revenue & Growth
  • Revenue has increased for 3 consecutive quarters.
  • Revenue of ₹2,366 Cr is 16.7% higher year-on-year.
  • Revenue has compounded at 25.4% annualised over the last 10 quarters.
  • Revenue is at its highest level in 10 quarters.
Profitability
  • Net profit of ₹323 Cr is 4.9% above the same quarter last year.
  • Profit growth is trailing revenue growth this quarter.
  • Net profit has compounded at 11.7% annualised across the period.
Margins
  • Operating margin stands at 25.3% in Q1 FY2027.
  • Operating margin compressed by 50 bps year-on-year.
  • Over the last two years operating margin has expanded by 18 bps.
  • PBT margin is 18.4%.
Operating Efficiency
  • Expenses grew 17.5% against revenue growth of 16.7%.
  • Operating profit of ₹598 Cr is 14.4% higher year-on-year.
  • Operating leverage has been under pressure recently.
Overall Momentum
  • 6 of the last 6 measured quarters delivered year-on-year revenue growth.
  • Overall quarterly business momentum scores 69/100 (Healthy) on the latest 10 quarters.
  • Business momentum remains positive heading into the next quarter.

Quarterly Financials

Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %

MetricTrend
Latest
Q1 FY2027
Q4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025Q4 FY2024
Revenue
Improving
2,366
2,1432,0682,1352,0281,9101,8681,7071,5431,423
Expenses
Improving
1,768
1,5361,5291,5601,5051,3981,3691,2571,1561,041
Operating Profit
Improving
598
606538575523512499451387382
Operating Margin
Stable
25.3%
28.3%26.0%26.9%25.8%26.8%26.7%26.4%25.1%26.8%
Other Income
Volatile
41
48-3333747-40413545
Interest
Strong Uptrend
71
676054555552342421
Depreciation
Improving
132
12311110810410198847770
Profit Before Tax
Improving
436
465365446400403309374321336
Tax
Volatile
113
12264-45928470928584
Net Profit
Improving
323
342301491308319239282236252
Net Margin
Stable
13.7%
16.0%14.6%23.0%15.2%16.7%12.8%16.5%15.3%17.7%
Source: Financial Intelligence (Structured Quarterly Data)Latest Quarter: Q1 FY2027Figures in ₹ Crore • Margins in %Automatically updated from Financial Intelligence · 2026-06-30

Key Takeaways

  • Revenue grew 16.7% YoY to ₹2,366 Cr, supported by organic growth and new acquisitions.
  • Completed acquisition of 58.28% stake in Kalinga Hospital (Bhubaneswar) for ₹298 Cr in May 2026.
  • Acquired 100% voting rights in Yerawada Properties (Pune) for ₹88 Cr to secure a 1.68-acre land parcel.
  • Board approved ₹425 Cr expansion for MSSH Vaishali to add ~250 beds by November 2029.
  • Network capacity utilization remained strong at over 75% for the quarter.
  • Reported a marginal decrease in sequential profit primarily due to higher finance costs and operational expenses.
  • Board approved in-principle exploring the setup of medical colleges under new NMC regulations.

Management Guidance

Management is focused on brownfield expansion and strategic acquisitions to drive growth, as evidenced by the new ₹425 Cr commitment for the Vaishali facility and the exploration of medical education institutions to complement hospital operations.

Sentiment Shift

Stable

While sequential margins saw pressure due to acquisition-related costs and finance charges, the strong YoY revenue growth and aggressive capacity expansion roadmap reinforce a growth-oriented outlook.

Expansionary
Strategic
Consolidating

Outlook

The company is aggressively scaling its footprint through both land acquisitions for greenfield projects (Pune) and hospital acquisitions (Odisha). The network is operating at high utilization (>75%), necessitating the announced brownfield expansions to sustain growth momentum through 2029.

From the Annual Report (Key Quotes)

Specifically, Capacity Utilization Network Hospitals in Q-1, FY’27 was >75%.

Approved capital expenditure of ~₹425 Crore towards the construction of an additional hospital block viz. ‘Tower 3’... part of the expansion plan of Max Super Speciality Hospital, Vaishali.

The acquisition [Kalinga Hospital] has been accounted for as a business combination... financial results for the quarter include those of KHL from May 18, 2026 and hence are not comparable with previous periods.

Official Quarterly Documents

Earnings Press Release
Official quarterly earnings release published by the company.
Download
Earnings Call Transcript
Management discussion and analyst Q&A.

Ask AI about this quarter

Sign in to ask AI questions grounded on the official earnings release and call transcript.

This summary is AI-generated from Max Healthcare Institute Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.

← Back to Max Healthcare Institute Limited AI analysis